外科理论与实践

外科理论与实践 >

2025 , Vol. 30 >Issue 05: 378 - 384

DOI: https://doi.org/10.16139/j.1007-9610.2025.05.02

专家论坛

超声内镜引导下腹腔神经丛阻滞术及其衍生技术进展

  • 敖心怡 ,
  • 李丽 ,
  • 李志 ,
  • 王凯旋
展开
  • 1.西南医科大学附属中医医院脾胃病科，四川 泸州 646000
    2.海军军医大学第一附属医院消化内科，上海 200433
    3.川北医学院中西医结合临床医学院，四川 南充 637100
王凯旋，E-mail: wangkaixuan224007@163.com

收稿日期: 2025-06-20

  网络出版日期: 2025-12-09

收起

Advances in endoscopic ultrasound-guided celiac plexus neurolysis and its derivative techniques

  • AO Xinyi ,
  • LI Li ,
  • LI Zhi ,
  • WANG Kaixuan
Expand
  • 1. Department of Spleen and Stomach Diseases, the Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, Sichuan Luzhou 646000, China
    2. Department of Gastroenterology, the First Affiliated Hospital of Naval Medical University, Shanghai 200433, China
    3. North Sichuan Medical College School of Clinical Integrated Traditional Chinese and Western Medicine，Sichuan Nanchong 637100，China

Received date: 2025-06-20

  Online published: 2025-12-09

Fold

摘要

本综述系统总结了超声内镜引导下腹腔神经丛阻滞术（EUS-CPN）及其衍生技术的临床应用与研究进展。内容涵盖适应证与禁忌证、操作难点与技术原则，并重点介绍了单侧与双侧注射、腹腔神经节神经松解术（EUS-CGN）、广泛神经丛阻滞法（EUS-BPN）以及射频消融、放射性粒子植入等多种路径。同时，对相关并发症及防治策略进行了总结，并对未来发展方向进行了展望，旨在为临床实践提供技术参考与决策依据。

关键词： 超声内镜; 腹腔神经丛阻滞术; 癌性疼痛; 神经节注射; 射频消融

本文引用格式

敖心怡 , 李丽 , 李志 , 王凯旋 . 超声内镜引导下腹腔神经丛阻滞术及其衍生技术进展[J]. 外科理论与实践, 2025 , 30(05) : 378 -384 . DOI: 10.16139/j.1007-9610.2025.05.02

Abstract

This review systematically summarizes the clinical applications and recent advances of endoscopic ultrasound-guided celiac plexus neurolysis (EUS-CPN) and its derived techniques. It addressed the indications, contraindications, technical challenges, and procedural principles, with a detailed overview of unilateral and bilateral injection, EUS-guided celiac ganglia neurolysis (EUS-CGN), EUS-guided broad-plexus neurolysis (EUS-BPN), as well as radiofrequency ablation and radioactive seed implantation. In addition, complications and their preventive strategies were discussed, and future directions were highlighted, aiming to provide technical references and decision-making guidance for clinical practice.

Key words： Endoscopic ultrasound (EUS); Celiac plexus neurolysis (CPN); Cancer pain; Ganglion injection; Radiofrequency ablation (RFA)

参考文献

[1] STEELE G L, DUDEK A Z, GILMORE G E, et al. Impact of pain, opioids, and the mu-opioid receptor on progression and survival in patients with newly diagnosed stage Ⅳ pancreatic cancer[J]. Am J Clin Oncol, 2020, 43(8):591-597.
[2] WIERSEMA M J, WIERSEMA L M. Endosonography-guided celiac plexus neurolysis[J]. Gastrointest Endosc, 1996, 44(6):656-662.
[3] ON W, AHMED W, EVERETT S, et al. Utility of interventional endoscopic ultrasound in pancreatic cancer[J]. Front Oncol, 2023,13:1252824.
[4] WYSE J M, BATTAT R, SUN S, et al. Practice guidelines for endoscopic ultrasound-guided celiac plexus neurolysis[J]. Endosc Ultrasound, 2017, 6(6):369-375.
[5] TEOH A Y B, DHIR V, KIDA M, et al. Consensus guidelines on the optimal management in interventional EUS procedures: results from the Asian EUS group RAND/UCLA expert panel[J]. Gut, 2018, 67(7):1209-1228.
[6] WYSE J M, SAHAI A V. Eus-guided celiac plexus neurolysis for pain in pancreatic cancer: when and how?[M]//Domínguez-Mu?oz J E. Clinical Pancreatology for Practising Gastroenterologists and Surgeons. John Wiley & Sons,2021:514-519.
[7] MINAGA K, KITANO M, SAKAMOTO H, et al. Predictors of pain response in patients undergoing endoscopic ultrasound-guided neurolysis for abdominal pain caused by pancreatic cancer[J]. Therap Adv Gastroenterol, 2016, 9(4):483-494.
[8] CHAN L K M, RAO T, MASANGCAY P, et al. A systema-tic review and meta-analysis of the efficacy of endoscopic ultrasound guided celiac plexus blocks for chronic pancreatitis pain[J]. J Pain Palliat Care Pharmacother, 2025, 39(2):254-265.
[9] STRAND D S, LAW R J, YANG D, et al. AGA clinical practice update on the endoscopic approach to recurrent acute and chronic pancreatitis: expert review[J]. Gastroenterology, 2022, 163(4):1107-1114.
[10] WILCOX C M, BANG J Y, BUXBAUM J, et al. Effect of endoscopic ultrasound guided celiac plexus block on the palliation of pain in chronic pancreatitis (EPOCH Trial): study protocol for a randomized multicenter sham-controlled trial {1}[J]. Trials, 2024, 25(1):676.
[11] LEVY M J, GLEESON F C, TOPAZIAN M D, et al. Combined celiac ganglia and plexus neurolysis shortens survival, without benefit, vs. plexus neurolysis alone[J]. Clin Gastroenterol Hepatol, 2019, 17(4):728-738.e9.
[12] AGSE Standards of Practice Committee, ACOSTA R D, ABRAHAM N S, et al. The management of antithrombotic agents for patients undergoing GI endoscopy[J]. Gastrointest Endosc, 2016, 83(1):3-16.
[13] SACHDEV A H, GRESS F G. Celiac plexus block and neurolysis: a review[J]. Gastrointest Endosc Clin N Am, 2018, 28(4):579-586.
[14] ROSENTHAL M H, LEE A, JAJOO K. Imaging and endoscopic approaches to pancreatic cancer[J]. Hematol Oncol Clin North Am, 2015, 29(4):675-699.
[15] KITANO M, KAMATA K. Advances in EUS[M]//JONNALAGADDA S S. Gastrointestinal endoscopy: new technologies and changing paradigms. Springer,2015:147-178.
[16] GLEESON F C, LEVY M J, PAPACHRISTOU G I, et al. Frequency of visualization of presumed celiac ganglia by endoscopic ultrasound[J]. Endoscopy, 2007, 39(7):620-624.
[17] 朱春辉, 王哲银, 凌地洋. CT-CPN和EUS-CPN在缓解胰腺癌所致癌性腹痛中的价值对比[J]. 现代诊断与治疗, 2019, 30(8):1303-1304.
  ZHU C H, WANG Z Y, LING D Y. Comparative value of CT?guided versus EUS?guided celiac plexus neurolysis for pancreatic cancer-related cancer pain[J]. Mod Diagn Treat, 2019, 30(8):1303?1304.
[18] OKITA M, OTANI K, GIBO N, et al. Systematic review and meta-analysis of celiac plexus neurolysis for abdominal pain associated with unresectable pancreatic cancer[J]. Pain Pract, 2022, 22(7):652-661.
[19] OKITA M, OTANI K, MATSUI S. Efficacy of endoscopic ultrasound-guided celiac plexus neurolysis for abdominal pain in patients with unresectable pancreatic cancer: network meta-analysis of randomized controlled trials[J]. J Clin Gastroenterol, 2023, 57(10):1054-1062.
[20] KOULOURIS A I, ALEXANDRE L, HART A R, et al. Endoscopic ultrasound-guided celiac plexus neurolysis (EUS-CPN) technique and analgesic efficacy in patients with pancreatic cancer: a systematic review and meta-analysis[J]. Pancreatology, 2021, 21(2):434-442.
[21] BHATNAGAR S, JOSHI S, RANA S P, et al. Bedside ultrasound-guided celiac plexus neurolysis in upper abdominal cancer patients: a randomized, prospective study for comparison of percutaneous bilateral paramedian vs. unilateral paramedian needle-insertion technique[J]. Pain Pract, 2014, 14(2):E63-E68.
[22] ASIF A A, WALAYAT S K, BECHTOLD M L, et al. EUS-guided celiac plexus neurolysis for pain in pancrea-tic cancer patients - a meta-analysis and systematic review[J]. J Community Hosp Intern Med Perspect, 2021, 11(4):536-542.
[23] SAHAI A V, LEMELIN V, LAM E, et al. Central vs. bila-teral endoscopic ultrasound-guided celiac plexus block or neurolysis: a comparative study of short-term effectiveness[J]. Am J Gastroenterol, 2009, 104(2):326-329.
[24] LEVY M J, TOPAZIAN M D, WIERSEMA M J, et al. Initial evaluation of the efficacy and safety of endoscopic ultrasound-guided direct Ganglia neurolysis and block[J]. Am J Gastroenterol, 2008, 103(1):98-103.
[25] XUAN M, LI N, WU C. A meta-analysis on the efficacy of endoscopic ultrasonography for treatment of pancreatic cancer[J]. Clinics (Sao Paulo), 2024,79:100348.
[26] DOI S, YASUDA I, KAWAKAMI H, et al. Endoscopic ultrasound-guided celiac ganglia neurolysis vs. celiac plexus neurolysis: a randomized multicenter trial[J]. Endoscopy, 2013, 45(5):362-369.
[27] ASCUNCE G, RIBEIRO A, REIS I, et al. EUS visualization and direct celiac ganglia neurolysis predicts better pain relief in patients with pancreatic malignancy (with video)[J]. Gastrointest Endosc, 2011, 73(2):267-274.
[28] HAO S J, XU W J, YANG D, et al. How to improve the efficacy of endoscopic ultrasound-guided celiac plexus neurolysis in pain management in patients with pancreatic cancer: analysis in a single center[J]. Surg Laparosc Endosc Percutan Tech, 2014, 24(1):31-35.
[29] KAMATA K, KINOSHITA M, KINOSHITA I, et al. Efficacy of EUS-guided celiac plexus neurolysis in combination with EUS-guided celiac ganglia neurolysis for pancreatic cancer-associated pain: a multicenter prospective trial[J]. Int J Clin Oncol, 2022, 27(7):1196-1201.
[30] ISHIWATARI H, HAYASHI T, YOSHIDA M, et al. Phenol-based endoscopic ultrasound-guided celiac plexus neurolysis for East Asian alcohol-intolerant upper gastrointestinal cancer patients: a pilot study[J]. World J Gastroenterol, 2014, 20(30):10512-10517.
[31] SINGH S, FACCIORUSSO A, VINAYEK R, et al. Endoscopic ultrasound-guided treatments for pancreatic cancer: understanding how endoscopic ultrasound has revolutionized management of pancreatic cancer[J]. Cancers(Basel), 2024, 17(1):89.
[32] SINGH G, KAUFMAN M S, ERBER J A, et al. M2032 efficacy of endoscopic ultrasound (EUS) guided celiac plexus neurolysis (CPN) for managing abdominal pain associated with pancreas cancer: a meta-analysis[J]. Gastroenterology, 2008, 134(4):A-454.
[33] LU F, DONG J, TANG Y, et al. Bilateral vs. unilateral endoscopic ultrasound-guided celiac plexus neurolysis for abdominal pain management in patients with pancreatic malignancy: a systematic review and meta-analysis[J]. Support Care Cancer, 2018, 26(2):353-359.
[34] MOUTINHO-RIBEIRO P, COSTA-MOREIRA P, CALDEIRA A, et al. Endoscopic ultrasound-guided celiac plexus interventions[J]. GE Port J Gastroenterol, 2020, 28(1):32-38.
[35] FUJII-LAU L L, BAMLET W R, ELDRIGE J S, et al. Impact of celiac neurolysis on survival in patients with pancreatic cancer[J]. Gastrointest Endosc, 2015, 82(1):46-56.e2.
[36] SAKAMOTO H, KITANO M, KAMATA K, et al. EUS-guided broad plexus neurolysis over the superior mesenteric artery using a 25-gauge needle[J]. Am J Gastroenterol, 2010, 105(12):2599-2606.
[37] GAI B, ZHANG F. Chinese expert consensus on radioactive (125)I seeds interstitial implantation brachytherapy for pancreatic cancer[J]. J Cancer Res Ther, 2018, 14(7):1455-1462.
[38] BANG J Y, SUTTON B, HAWES R H, et al. EUS-guided celiac ganglion radiofrequency ablation versus celiac plexus neurolysis for palliation of pain in pancreatic cancer: a randomized controlled trial (with videos)[J]. Gastrointest Endosc, 2019, 89(1):58-66.
[39] SINGH S, SHEPHERD K, MAAN S, et al. EUS guided radiofrequency ablation (RFA) of celiac ganglion using a novel RFA needle for pain management in patients with pancreatic cancer: a pilot study[J]. Gastrointestinal Endoscopy, 2025, 101(5):S546-S547.
[40] JIN Z, DU Y, LI Z, et al. Endoscopic ultrasonography-guided interstitial implantation of iodine 125-seeds combined with chemotherapy in the treatment of unresectable pancreatic carcinoma: a prospective pilot study[J]. Endoscopy, 2008, 40(4):314-320.
[41] WANG K X, JIN Z D, DU Y Q, et al. EUS-guided celiac ganglion irradiation with iodine-125 seeds for pain control in pancreatic carcinoma: a prospective pilot study[J]. Gastrointest Endosc, 2012, 76(5):945-952.
[42] TIAN L, LI Z, WANG X. Tu1371 combined EUS-guided celiac plexus neurolysis and Iodine-125 versus EUS-guided celiac plexus neurolysis for palliation of pain in pancreatic cancer: a prospective, randomized study[J]. Gastrointestinal Endoscopy, 2019, 89(6):AB595.
[43] ZHANG P P, SU X J, LI L, et al. Clinical efficacy of EUS-guided celiac plexus neurolysis versus EUS-guided celiac ganglion irradiation with iodine-125 seeds for pain relief in advanced pancreatic cancer: a long-term retrospective study[J]. Endosc Ultrasound, 2024, 13(2):100-106.
[44] ALVAREZ-SáNCHEZ M V, JENSSEN C, FAISS S, et al. Interventional endoscopic ultrasonography: an overview of safety and complications[J]. Surg Endosc, 2014, 28(3):712-734.
[45] LAKHTAKIA S. Complications of diagnostic and therapeutic endoscopic ultrasound[J]. Best Pract Res Clin Gastroenterol, 2016, 30(5):807-823.
[46] AHMED H M, FRIEDMAN S E, HENRIQUES H F, et al. End-organ ischemia as an unforeseen complication of endoscopic-ultrasound-guided celiac plexus neurolysis[J]. Endoscopy, 2009, 41(Suppl 2):E218-E219.
[47] FUJII L, CLAIN J E, MORRIS J M, et al. Anterior spinal cord infarction with permanent paralysis following endoscopic ultrasound celiac plexus neurolysis[J]. Endoscopy, 2012, 44(Suppl 2 UCTN):E265-E266.
[48] GIMENO-GARCíA A Z, ELWASSIEF A, PAQUIN S C, et al. Fatal complication after endoscopic ultrasound-guided celiac plexus neurolysis[J]. Endoscopy, 2012, 44 (Suppl 2 UCTN):E267.
[49] MINAGA K, KITANO M, IMAI H, et al. Acute spinal cord infarction after EUS-guided celiac plexus neurolysis[J]. Gastrointest Endosc, 2016, 83(5):1039-1040.
[50] MITTAL M K, RABINSTEIN A A, WIJDICKS E F. Pearls & oy-sters: acute spinal cord infarction following endoscopic ultrasound-guided celiac plexus neurolysis[J]. Neurology 2012, 78(9):e57-e59.
[51] ZHAO Y, GUO X, WANG K, et al. A retrospective multicenter study comparing bupivacaine and ropivacaine in endoscopic ultrasound guided celiac plexus neurolysis[J]. Ann Palliat Med, 2021, 10(2):1755-1762.
[52] ESMAIL E, PAQUIN S C, SAHAI A V. Protocol for a randomized controlled trial of endoscopic ultrasound guided celiac plexus neurolysis (EUS-CPN) with vs. without bupivacaine[J]. Trials, 2023, 24(1):576.
Options
文章导航

/

〈 〉